Center for Military Biomaterials ResearchIntegrated Technologies for Polymeric Biomaterials
 
Cells on Polymeric Biomaterials - a 3-day RESBIO short course, Fall 2009

Trident Biomedical, Inc. to Commercialize Rutgers’ Polymer Technologies for Advanced Medical Applications
Rutgers University and Trident Biomedical, Inc. (Trident), have announced an extensive license agreement covering a portfolio of more than 50 biomaterial patents and patent applications. 




SAVE THE DATES FOR OUR UPCOMING EVENTS

CLICK HERE TO REGISTER FOR THE SKIN DEEP SYMPOSIUM



Wednesday, July 15, 2009 - Skin Deep Symposium
Resources for Scientists & Entrepreneurs

Fall  2009 - Rutgers Pharmaceutics Conference - Date TBA


NJCBM Director Kohn Testifies at Congressional Hearing on Impact of NIH Funding, November 13, 2008 - Full Text of Testimony (PDF)

U.S. Department of Defense creates new federally-funded institution with $85 million
NJ Center for Biomaterials to lead 15-university consortium within the Armed Forces Institute for Regenerative Medicine - AFIRM

NJCBM Partners with new Rutgers Professional Science Masters Program

   
   
   
 
Serving New Jersey and the World
Email:
Password:
  The programs of the New Jersey Center for Biomaterials aim to stimulate biomedical innovation that will benefit society and contribute to economic growth.   We strive to embody research excellence through the Center’s NIH-funded Technology Resource for Polymeric Biomaterials (RESBIO) and the DOD-funded Center for Military Biomaterials Research and Armed Forces Institute of Regenerative MedicineNetworking and professional development opportunities within and beyond the state are promoted through our partnerships with industry, while our various academic programs help to shape New Jersey’s educational output and workforce.  Finally, through the Center’s spin-off companies, active licenses, and R&D agreements, our goal is to directly impact New Jersey's economy and entrepreneurship initiatives. 

 
Search: